Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
0.9101
-0.0195 (-2.10%)
At close: Oct 9, 2026, 4:00 PM EDT
0.9095
-0.0006 (-0.07%)
After-hours: Oct 9, 2026, 7:42 PM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $3.25 million as of October 9, 2026. It is the 46,610th most valuable company in the world and the 6,265th biggest in the United States. Its market cap has decreased by 88.64% in one year.
Market Cap
3.25M
Enterprise Value
858.73K
1-Year Change
-88.64%
Global Rank
Country Rank
#6,265 United States
Category
ChartMarket Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $3.25M, a decrease of -94.42%. That is a compound annual growth rate of -53.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 3.25M | -79.52% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jupiter Neurosciences | 3.76M |
| Eocene | 3.69M |
| HCW Biologics | 3.58M |
| Addex Therapeutics | 3.56M |
| 60 Degrees Pharmaceuticals | 3.40M |
| Aptevo Therapeutics | 3.23M |
| Propanc Biopharma | 3.08M |
| Mustang Bio | 3.03M |